XML 47 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 9 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2012
Successor [Member]
Dec. 31, 2013
Successor [Member]
Mar. 19, 2012
Predecessor [Member]
Dec. 31, 2011
Predecessor [Member]
Cash flows from operating activities:        
Net income (loss) $ (12,353) $ 338 $ (3,433) $ (10,873)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities before reorganization activities:        
Amortization of bond premium or discount 1,837 2,309 523 2,750
Net realized (gain) loss on sale of investments (2,747) 1,575 (176) (1,206)
Unrealized (gain) loss on trading securities 1,410 3,492 (1,049) 2,828
Equity-based compensation expense 143 401    
Changes in assets and liabilities:        
Accrued investment income 616 588 309 889
Deferred offering costs   (1,071)    
Other assets 1,588 338 (597) 1,385
Change in cash held in trust 9,230 (16,074) 7,209 3,998
Change in restricted cash (25,169) 25,054    
Losses and loss adjustment reserves (58,485) (38,210) (1,109) (47,917)
Losses payable (5,445) 377 1,662 (6,498)
Unearned premiums (184) 1,169 (47) (222)
Accrued ceding commission expense (330) (34) 137 (259)
Accrued interest on notes payable 1,476 (333)    
Loss contract fair market value reserve (10,847) (5,898)    
Other liabilities (3,514) 682 414 2,033
Total adjustments (90,421) (25,635) 7,276 (42,219)
Net cash (used in) provided by operating activities (102,774) (25,297) 3,843 (53,092)
Cash flows from investing activities:        
Purchase of investments (202,847) (430,983) (38,506) (147,993)
Proceeds from sales and maturities of investments 234,096 482,275 34,035 206,789
Net cash provided by (used in) investing activities 31,249 51,292 (4,471) 58,796
Cash flows from financing activities:        
Cash from (used in) reorganization activities     75,000  
Notes payable-principal repayments (2,064) (36,294)    
Notes payable-principal issued 8,336 5,524    
Net cash (used in) provided by financing activities 6,272 (30,770) 75,000  
(Decrease) increase in cash and cash equivalents (65,253) (4,775) 74,372 5,704
Cash and cash equivalents, beginning of period 82,014 16,761 7,642 1,938
Cash and cash equivalents, end of period 16,761 11,986 82,014 7,642
Cash paid during the year:        
Interest 3,699 9,707    
Supplementary disclosure of non-cash investing and financing activities:        
Notes payable issued in lieu of cash interest payments $ 8,336 $ 5,524